Browse > Article
http://dx.doi.org/10.7314/APJCP.2015.16.9.3621

Associations of Probiotics with Vitamin D and Leptin Receptors and their Effects on Colon Cancer  

Ranji, Peyman (Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, International Branch of Tabriz University of Medical sciences (Aras))
Akbarzadeh, Abolfazl (Drug Applied Research Center, Faculty of Advanced Medical Sciences, Tabriz University of Medical sciences)
Rahmati-Yamchi, Mohammad (Drug Applied Research Center, Faculty of Advanced Medical Sciences, Tabriz University of Medical sciences)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.16, no.9, 2015 , pp. 3621-3627 More about this Journal
Abstract
Colorectal cancer (CRC) is one of most common causes of cancer-related death worldwide. Recent studies have suggested that microbial and environmental factors including diet and lifestyle can impact on colon cancer development. Vitamin D deficiency and dysfunction of vitamin D receptor (VDR) also correlate with colon cancer. Moreover, leptin, a 16-kDa polypeptide, participates in the regulation of food intake and is associated with other environmental factors affecting colon cancer through the leptin receptor. Altered levels of serum leptin and patterns of expression of its receptor (LPR) may be observed in human colon tumours. Furthermore, the collected data from in vitro and in vivo studies have indicated that consuming probiotic non-pathogenic lactic acid bacteria have beneficial effects on colon cancer. Probiotics, inflammation and vitamin D/VDR have been correlated with leptin and its receptor and are also with colon cancer. Thus, in this paper, we review recent progress on the roles of probiotic, vitamin D/VDR and leptin/LPR in inflammation and colon cancer.
Keywords
Colon cancer; leptin; leptin receptor; probiotic; vitamin D; vitamin D receptor;
Citations & Related Records
Times Cited By KSCI : 5  (Citation Analysis)
연도 인용수 순위
1 Lee NK, Park JS, Park E, et al (2007). Adherence and anticarcinogenic effects of Bacillus polyfermenticus SCD in the large intestine. Letters in Applied Microbiol, 44, 274-8.   DOI
2 Leung K-C (2004). Regulation of cytokine receptor signaling by nuclear hormone receptors: a new paradigm for receptor interaction. DNA and Cell Biology, 23, 463-74.   DOI
3 Lu R, Wu S, Xia Y, et al (2012). The vitamin D receptor, inflammatory bowel diseases, and colon cancer. Current Colorectal Cancer Reports, 8, 57-65.   DOI
4 Matilainen JM, Rasanen A, Gynther P, et al (2010). The genes encoding cytokines IL-2, IL-10 and IL-12B are primary 1${\alpha}$, 25 (OH) 2 D 3 target genes. J Steroid Biochemistry and Molecular Biology, 121, 142-5.   DOI
5 Matsunuma A, Horiuchi N (2007). Leptin attenuates gene expression for renal 25-hydroxyvitamin D 3-1${\alpha}$-hydroxylase in mice via the long form of the leptin receptor. Arch Biochem Biophys, 463, 118-27.   DOI
6 McEwan IJ 2009. Nuclear receptors: one big family, Springer.
7 Mencarelli A, Distrutti E, Renga B, et al (2011). Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation. PLoS One, 6, 22978.   DOI
8 Menendez C, Lage M, Peino R, et al (2001). Retinoic acid and vitamin D (3) powerfully inhibit in vitro leptin secretion by human adipose tissue. J Endocrinol, 170, 425-31.   DOI
9 Mirza NN, McCloud JM, Cheetham MJ (2009). Clostridium septicum sepsis and colorectal cancer-a reminder. World J Surg Oncol, 7, 73.   DOI
10 Salageanu A (2010). Serum levels of adipokines resistin and leptin in patients with colon cancer. J Med Life, 3, 416.
11 Samuel S, Sitrin MD (2008). Vitamin D's role in cell proliferation and differentiation. Nutrition reviews, 66, 116-24.   DOI
12 Schauber J, Dorschner RA, Coda AB, et al (2007). Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. The J Clin Invest, 117, 803-11.   DOI
13 Sentongo TA, Semaeo EJ, Stettler N, et al (2002). Vitamin D status in children, adolescents, and young adults with Crohn disease. Am J Clin Nutr, 76, 1077-81.
14 Shamsuzzaman AS, Winnicki M, Wolk R, et al (2004). Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation, 109, 2181-5.   DOI
15 Slattery M, Ballard-Barbash R, Edwards S, et al (2003). Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes Control, 14, 75-84.   DOI
16 Slattery ML, Curtin K, Sweeney C, et al (2007). Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int J Cancer, 120, 656-63.   DOI
17 Slattery ML, Wolff RK, Herrick J, et al (2008). Leptin and leptin receptor genotypes and colon cancer: Gene-gene and gene-lifestyle interactions. Int J Cancer, 122, 1611-7.
18 Sonoda J, Pei L, Evans RM (2008). Nuclear receptors: decoding metabolic disease. FEBS letters, 582, 2-9.   DOI
19 Stubbins RE, Hakeem A, Nunez NP (2012). Using components of the vitamin D pathway to prevent and treat colon cancer. Nutr Rev, 70, 721-9.   DOI
20 Yoon S, Wu S, Zhang Y-g, et al (2011). Probiotic regulation of vitamin D receptor in intestinal inflammation. Gastroenterology, 140, S-19.
21 Yoon SS, Sun J (2011). Probiotics, nuclear receptor signaling, and anti-inflammatory pathways. Gastroenterology research and practice, 2011.
22 Yu K, Yang J, Jiang Y, et al (2014). Vitamin D receptor BsmI polymorphism and colorectal cancer risk: an updated analysis. Asian Pac J Cancer Prev, 15, 4801-7.   DOI
23 Zheng W, Wong KE, Zhang Z, et al (2012). Inactivation of the vitamin D receptor in APCmin/+ mice reveals a critical role for the vitamin D receptor in intestinal tumor growth. Int J Cancer, 130, 10-9.   DOI
24 Zhu Y, Michelle Luo T, Jobin C, et al (2011). Gut microbiota and probiotics in colon tumorigenesis. Cancer Lett, 309, 119-27.   DOI
25 Zinser GM, Suckow M, Welsh J (2005). Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues. J Steroid Biochem Mol Biol, 97, 153-64.   DOI
26 Akinci MB, Sendur M, Aksoy S, et al (2014). Serum 25-hydroxy Vitamin D status is not related to osteopenia/osteoporosis risk in colorectal cancer survivors. Asian Pac J Cancer Prev: APJCP, 15, 3377.   DOI
27 Abreu M, Kantorovich V, Vasiliauskas E, et al (2004). Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1, 25-dihydroxyvitamin D and low bone mineral density. Gut, 53, 1129-36.   DOI
28 Abreu MT, Peek RM, Jr. (2014). Gastrointestinal malignancy and the microbiome. Gastroenterology, 146, 1534-46.   DOI
29 Ahima RS, Osei SY (2004). Leptin signaling. Physiology & Behavior, 81, 223-41.   DOI
30 Al-Jashamy K, Murad A, Zeehaida M, et al (2010). Prevalence of colorectal cancer associated with Streptococcus bovis among inflammatory bowel and chronic gastrointestinal tract disease patients. Asian Pac J Cancer Prev, 11, 1765-8.
31 Aloulou N, Bastuji-Garin S, Le Gouvello S, et al (2008). Involvement of the leptin receptor in the immune response in intestinal cancer. Cancer Res, 68, 9413-22.   DOI
32 Bolukbas FF, Kilic H, Bolukbas C, et al (2004). Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study. BMC Cancer, 4, 29.   DOI
33 Aparicio T, Kotelevets L, Tsocas A, et al (2005). Leptin stimulates the proliferation of human colon cancer cells in vitro but does not promote the growth of colon cancer xenografts in nude mice or intestinal tumorigenesis in ApcMin/+ mice. Gut, 54, 1136-45.   DOI
34 Bartucci M, Svensson S, Ricci-Vitiani L, et al (2010). Obesity hormone leptin induces growth and interferes with the cytotoxic effects of 5-fluorouracil in colorectal tumor stem cells. Endocrine-related Cancer, 17, 823-33.   DOI
35 Basseri RJ, Basseri B, Papadakis KA (2011). Dysplasia and cancer in inflammatory bowel disease.   DOI
36 Bouillon R, Carmeliet G, Verlinden L, et al (2008). Vitamin D and human health: lessons from vitamin D receptor null mice. Endocrine Reviews, 29, 726-76.   DOI
37 Carlberg C, Dunlop TW (2006). The impact of chromatin organization of vitamin D target genes. Anticancer Research, 26, 2637-45.
38 Collins AT, Berry PA, Hyde C, et al (2005). Prospective identification of tumorigenic prostate cancer stem cells. Cancer research, 65, 10946-51.   DOI
39 Davis CD, Milner JA (2009). Gastrointestinal microflora, food components and colon cancer prevention. J Nutritional Biochemistry, 20, 743-52.   DOI
40 Drew JE (2012). Molecular mechanisms linking adipokines to obesity-related colon cancer: focus on leptin. Proceedings of the Nutrition Society, 71, 175-80.   DOI
41 Guarner F, Malagelada J-R (2003). Gut flora in health and disease. The Lancet, 361, 512-9.   DOI
42 Endo H, Hosono K, Uchiyama T, et al (2011). Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis. Gut, 2010, 235754.
43 Fearon ER (2011). Molecular genetics of colorectal cancer. Annual Review of Pathology: Mechanisms of Disease, 6, 479-507.   DOI
44 Gianotti L, Morelli L, Galbiati F, et al (2010). A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients. World journal of gastroenterology: WJG, 16, 167.   DOI
45 Hardwick JC, Van Den Brink GR, Offerhaus G, et al (2001). Leptin is a growth factor for colonic epithelial cells. Gastroenterology, 121, 79-90.   DOI
46 Hoda M, Keely S, Bertelsen L, et al (2007). Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells. Br J Surg, 94, 346-54.   DOI
47 Holick MF (2010). Vitamin D and health: evolution, biologic functions, and recommended dietary intakes for vitamin D. In 'Vitamin D', Eds Springer, 3-33
48 Huang P, Chandra V, Rastinejad F (2010). Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics. Annu Rev Physiol, 72, 247-72.   DOI
49 Hui L, Desen W, Zhizhong P, et al (2011). Expression and biological significance of leptin, leptin receptor, VEGF, and CD34 in colorectal carcinoma. Cell Biochem Biophysics, 60, 241-4.   DOI
50 Ishikawa H, Akedo I, Otani T, et al (2005). Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int J Cancer, 116, 762-7.   DOI
51 Kailasapathy K, Chin J (2000). Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunology and Cell Biology, 78, 80-8.   DOI
52 Ishikawa M, Kitayama J, Nagawa H (2004). Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res, 10, 4325-31.   DOI
53 Isono M, Inoue R, Kamida T, et al (2003). Significance of leptin expression in invasive potential of pituitary adenomas. Clin Neurol Neurosurgery, 105, 111-6.   DOI
54 Joshi RK, Lee S-A (2014). Obesity related adipokines and colorectal cancer: a review and meta-analysis. Asian Pac J Cancer Prev, 15, 397-405.   DOI   ScienceOn
55 Kaji R, Kiyoshima-Shibata J, Nagaoka M, et al (2010). Bacterial teichoic acids reverse predominant IL-12 production induced by certain lactobacillus strains into predominant IL-10 production via TLR2-dependent ERK activation in macrophages. J Immunol, 184, 3505-13.   DOI
56 Kotnis A, Sarin R, Mulherkar R (2005). Genotype, phenotype and cancer: role of low penetrance genes and environment in tumour susceptibility. J Biosciences, 30, 93-102.   DOI
57 Kumar M, Nagpal R, Verma V, et al (2013). Probiotic metabolites as epigenetic targets in the prevention of colon cancer. Nutr Rev, 71, 23-34.   DOI
58 Kumor A, Daniel P, Pietruczuk M, et al (2009). Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Disease, 24, 275-81.   DOI
59 Lagishetty V, Misharin AV, Liu NQ, et al (2010). Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology, 151, 2423-32.   DOI
60 Mu H-J, Zou J, Xie P, et al (2014). Association of leptin receptor Lys109Arg and Gln223Arg polymorphisms with increased risk of clear cell renal cell carcinoma. Asian Pac J Cancer Prev, 15, 4211-5.   DOI
61 O'mahony L, Feeney M, O'halloran S, et al (2001). Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Alimentary Pharmacology & Therapeutics, 15, 1219-25.   DOI
62 Palmer HG, Gonzalez-Sancho JM, Espada J, et al (2001). Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol, 154, 369-87.   DOI
63 Pendas-Franco N, Aguilera O, Pereira F, et al (2008). Vitamin D and Wnt/${\beta}$-catenin pathway in colon cancer: role and regulation of DICKKOPF genes. Anticancer Research, 28, 2613-23.
64 Pereira F, Larriba MJ, Munoz A (2012). Vitamin D and colon cancer. Endocrine-related cancer, 19, 51-71.   DOI
65 Ramagopalan SV, Heger A, Berlanga AJ, et al (2010). A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Research, 20, 1352-60.   DOI
66 Rasool S, Kadla SA, Khan T, et al (2013). Association of a VDR gene polymorphism with risk of colorectal cancer in Kashmir. Asian Pac J Cancer Prev, 14, 5833-7.   DOI   ScienceOn
67 Reiff C, Delday M, Rucklidge G, et al (2009). Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL# 3, a biotherapeutic agent, in the treatment of inflammatory bowel disease. Inflammatory Bowel Diseases, 15, 1721-36.   DOI
68 Reya T, Clevers H (2005). Wnt signalling in stem cells and cancer. Nature, 434, 843-50.   DOI
69 Suzuki T, Franchi L, Toma C, et al (2007). Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS pathogens, 3, 111.   DOI   ScienceOn
70 Sun J (2010). Vitamin D and mucosal immune function. Curr Opinion Gastroenterology, 26, 591.   DOI
71 Thorne J, Campbell MJ (2008). The vitamin D receptor in cancer. Proc Nutrition Society, 67, 115-27.   DOI   ScienceOn
72 Tutino V, Notarnicola M, Guerra V, et al (2011). Increased soluble leptin receptor levels are associated with advanced tumor stage in colorectal cancer patients. Anticancer Res, 31, 3381-3.
73 Uchiyama T, Takahashi H, Endo H, et al (2011). Role of the long form leptin receptor and of the STAT3 signaling pathway in colorectal cancer progression. Int J Oncol, 39, 935.
74 Urbanska AM, Bhathena J, Martoni C, et al (2009). Estimation of the potential antitumor activity of microencapsulated Lactobacillus acidophilus yogurt formulation in the attenuation of tumorigenesis in Apc (Min/+) mice. Dig Dis Sci, 54, 264-73.   DOI
75 Wada K, Tanaka H, Maeda K, et al (2009). Vitamin D receptor expression is associated with colon cancer in ulcerative colitis. Oncology reports, 22, 1021.
76 Weiss ST (2011). Bacterial components plus vitamin D: the ultimate solution to the asthma (autoimmune disease) epidemic? J Allergy Clin Immunol Pract, 127, 1128.   DOI
77 Wu S, Liao AP, Xia Y, et al (2010). Vitamin D receptor negatively regulates bacterial-stimulated NF-${\kappa}B$ activity in intestine. Am J Pathol, 177, 686-97.   DOI
78 Wu S, Sun J (2011). Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection. Discovery Med, 11, 325.